NEW YORK – To further expand on the understanding of and identify possible therapeutic targets for childhood ependymoma, a team of researchers from the University of Colorado Denver has studied the cellular diversity of this type of brain tumor using single-cell transcriptome sequencing.
Ependymoma remains fatal in most children, is incurable, and has not seen new therapies in several decades. In previous studies, scientists have mostly analyzed bulk tumor samples.